GeneLancet Biosciences

Primary NAICS Code

541714

Headquarters

Doylestown, PA

UEI

DN5PLRA5PM23

CAGE

8Q692

GeneLancet Biosciences is a precise gene editing company that develops proprietary LgRNA technology for scalable, high-purity guide RNA production and non-immunogenic STAR editors for therapeutic applications. The company focuses on cures for neurodegenerative disorders, cancers, and chronic viral infections.

• AUM LifeTech, IncAUM LifeTech is a Philadelphia-based biotechnology company that develops and manufactures self-delivering FANA antisense oligonucleotide (ASO) technology for RNA silencing and gene regulation. The company produces research and pre-clinical products for targeting mRNA, microRNA, and long non-coding RNA in genetically defined diseases.PHILADELPHIA, PA
• CerespectusCerespectus is a medical device company specializing in the development of an innovative catheter delivery system for targeted gene therapy to treat central nervous system (CNS) related disorders. The company designs, develops, and commercializes multi-lumen catheters with a camera system for visualization.PHILADELPHIA, PA
• PeriphaGenPeriphaGen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector for neurologic disease. The company has developed a replication defective HSV-1 vector platform called 'Neuronal Therapeutics' (NET) for delivery of tissue specific gene expression in sensory neurons from a simple skin administration. PeriphaGen's lead product, PGN-503, is designed to prevent or treat peripheral neuropathy in patients receiving chemotherapy.PITTSBURGH, PA
• Puresyn, IncPuresyn, Inc. manufactures high-quality plasmid DNA for cell and gene therapy development using proprietary PolyFlo® resin. The company offers services from discovery through commercialization, including Transfection Ready, Research Ready, IND Ready, and cGMP plasmid DNA production in ISO Certified cleanroom facilities.325412MALVERN, PA